Nordea Investment Management
AGN

Nordea Investment Management’s Allergan Inc AGN Stock Holding History

Nordea Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,728
Closed -$2.07M – 980
2014
Q4 		$2.07M Sell
9,728
-2,027
-17% -$403K 0.01% 362
2014
Q3 		$2.1M Sell
11,755
-130,520
-92% -$21.7M 0.01% 366
2014
Q2 		$24.1M Sell
142,275
-109,644
-44% -$17.1M 0.1% 158
2014
Q1 		$31.3M Sell
251,919
-52,898
-17% -$6.44M 0.15% 135
2013
Q4 		$33.9M Buy
304,817
+42,455
+16% +$4.06M 0.17% 130
2013
Q3 		$23.7M Sell
262,362
-44,151
-14% -$3.96M 0.13% 140
2013
Q2 		$25.8M Buy
+306,513
New +$31.8M 0.16% 115

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Nordea Investment Management's AGN Position: Q1 2015 in Review

Nordea Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 9,728 shares — an estimated $2.07M sold.

Nordea Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $33.9M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Nordea Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Nordea Investment Management sold 9,728 Allergan Inc shares in Q1 2015, an estimated $2.07M.
  • Nordea Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Nordea Investment Management's Allergan Inc position peaked at $33.9M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Nordea Investment Management's 13F filing for Q1 2015, filed 24 Apr 2015.